Positron emission tomography in schizophrenic patients with and without neuroleptic medication (Q48486242)

11 February 2018

title

Positron emission tomography in schizophrenic patients with and without neuroleptic medication (English)

1 reference

11 February 2018

positron emission tomography

main subject

schizophrenia

0 references

1 reference

DeLisi LE

1 reference

11 February 2018

Holcomb HH

1 reference

11 February 2018

Cohen RM

1 reference

11 February 2018

Pickar D

1 reference

11 February 2018

Carpenter W

1 reference

11 February 2018

Morihisa JM

1 reference

11 February 2018

King AC

1 reference

11 February 2018

Kessler R

1 reference

11 February 2018

Buchsbaum MS

1 reference

11 February 2018

publication date

1 June 1985

1 reference

11 February 2018

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

11 February 2018

volume

1 reference

11 February 2018

issue

1 reference

11 February 2018

page(s)

201-206

1 reference

11 February 2018

Patterns of metabolic activity in the treatment of schizophrenia.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1985.26

Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1985.26

Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1985.26

Clinical correlates of decreased anteroposterior metabolic gradients in positron emission tomography (PET) of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1985.26

Prospects for both precision and accuracy in positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1985.26

Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1985.26

Distribution of cerebral activity in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1985.26

Human sensory stimulation and deprivation: positron emission tomographic results and strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1985.26

Distribution of effects of haloperidol on energy metabolism in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1985.26

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1985.26

15O positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1985.26

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1985.26

Imaging dopamine receptors in the human brain by positron tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1985.26

Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1985.26

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/JCBFM.1985.26

1 reference

11 February 2018

1 reference

11 February 2018